Sequenom IncMost RecentCompany & Industry OverviewsInvestors Not Impressed with Immunomedics’ IMMU-132 StudyOn June 6, 2016, biotech stocks continued their upward trend and appeared to be in a positive, consolidating mood. IBB rose 1.5% that day.
Company & Industry OverviewsInvestors Not Impressed with Immunomedics’ IMMU-132 StudyOn June 6, 2016, biotech stocks continued their upward trend and appeared to be in a positive, consolidating mood. IBB rose 1.5% that day.
